Experiment summary for ENCSR864RGX
doi:10.17989/ENCSR864RGX
Summary
- Status
- released
- Assay
- Mint-ChIP-seq
- Target
- H3K27ac
- Biosample summary
- Homo sapiens activated naive CD8-positive, alpha-beta T cell male adult (30 years) treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days
- Biosample Type
- primary cell
- Replication type
- unreplicated
- Treatments
- anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 (UniProtKB:P60568) for 5 days
- Nucleic acid type
- DNA
- Platform
- Illumina NextSeq 500
- Controls
Attribution
ENCODE4 project
- Lab
- Bradley Bernstein, Broad
- Award
- UM1HG009390 (Bradley Bernstein, Broad)
- Project
- ENCODE
- External resources
- Aliases
- bradley-bernstein:Project Element 6896
- Date released
- April 27, 2022
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 2 | Homo sapiens male adult (30 years) activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days | ENCBS715FVA | ENCAB101KHB | ENCLB346GBZ |
| 1 | 1 | Homo sapiens male adult (30 years) activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days | ENCBS715FVA | ENCAB101KHB | ENCLB642RQZ |